Throughout the current 3 months, 10 experts have actually shared their insights on Kymera Rehabs (NASDAQ: KYMR), revealing a range of viewpoints covering from bullish to bearish.
The table listed below summarizes their current rankings, showcasing the developing beliefs within the previous one month and comparing them to the preceding months.
| Bullish | Rather Bullish | Indifferent | Rather Bearish | Bearish | |
|---|---|---|---|---|---|
| Overall Rankings | 6 | 4 | 0 | 0 | 0 |
| Last 30D | 1 | 0 | 0 | 0 | 0 |
| 1M Ago | 3 | 1 | 0 | 0 | 0 |
| 2M Ago | 2 | 3 | 0 | 0 | 0 |
| 3M Ago | 0 | 0 | 0 | 0 | 0 |
Experts have actually just recently assessed Kymera Rehabs and offered 12-month cost targets. The typical target is $74.1, accompanied by a high price quote of $90.00 and a low price quote of $60.00. This upward pattern appears, with the present typical showing a 25.23% boost from the previous typical cost target of $59.17.
Figuring Out Expert Rankings: An Extensive Analysis
A clear image of Kymera Rehabs’s understanding amongst economists is painted with an extensive analysis of current expert actions. The summary listed below lays out crucial experts, their current examinations, and modifications to rankings and cost targets.
| Expert | Expert Company | Action Taken | Score | Present Rate Target | Previous Rate Target |
|---|---|---|---|---|---|
| Andrew S. Fein | HC Wainwright & & Co. | Raises | Buy | $ 84.00 | $ 70.00 |
| Brad Canino | Guggenheim | Reveals | Buy | $ 90.00 | – |
| Jeet Mukherjee | BTIG | Raises | Buy | $ 75.00 | $ 59.00 |
| Joseph Catanzaro | Mizuho | Reveals | Outperform | $ 81.00 | – |
| Geoff Meacham | Citigroup | Raises | Buy | $ 80.00 | $ 60.00 |
| Jeff Jones | Oppenheimer | Raises | Outperform | $ 63.00 | $ 53.00 |
| Srikripa Devarakonda | Truist Securities(* )Raises | Buy | $ 68.00 | $ 53.00 | Andrew S. Fein |
| HC Wainwright & Co. | Raises | Buy | $ 70.00 | $ 60.00 | Etzer Darout |
| Barclays | Reveals | Obese | $ 60.00 | – | Brian Abrahams |
| RBC Capital | Reveals | Outperform | $ 70.00 | – | Secret Insights: |
Action Taken:(* )Experts often upgrade their suggestions based upon developing market conditions and business efficiency. Whether they ‘Maintain’, ‘Raise’ or ‘Lower’ their position, it shows their response to current advancements associated with Kymera Rehabs. This details offers a photo of how experts view the present state of the business.
- Score: Providing insights into forecasts, experts designate qualitative worths, from ‘Outperform’ to ‘Underperform’. These rankings communicate expectations for the relative efficiency of Kymera Rehabs compared to the more comprehensive market.
- Rate Targets: Experts check out the characteristics of cost targets, supplying quotes for the future worth of Kymera Rehabs’s stock. This evaluation exposes shifts in experts’ expectations gradually.
- Evaluating these expert examinations along with appropriate monetary metrics can supply an extensive view of Kymera Rehabs’s market position. Stay notified and make data-driven choices with the support of our Rankings Table. Stay up to date on Kymera Rehabs expert rankings.
About Kymera Rehabs
Kymera Rehabs Inc is a clinical-stage biopharmaceutical business committed to transforming the treatment of human illness through the advancement of, separated medications that deal with health issue which meaningfully enhance clients’ lives. It is devoted to unique innovations to deal with targets that have actually understood disease-causing biology, however which have actually not been drugged, or have actually been improperly drugged, typically based upon constraints of existing innovations. Its method is meant to find and establish a brand-new generation of medications in a disease-agnostic way. Its item pipelines are STAT6, TYK2, and IRAK4.
Comprehending the Numbers: Kymera Rehabs’s Financial resources
Market Capitalization Analysis:
The business displays a lower market capitalization profile, placing itself listed below market averages. This recommends a smaller sized scale relative to peers.
Decrease in Profits: Over the 3M duration, Kymera Rehabs dealt with obstacles, leading to a decrease of around
-55.26% in earnings development since 30 June, 2025. This represents a decrease in the business’s top-line incomes. When compared to others in the Healthcare sector, the business deals with obstacles, accomplishing a development rate lower than the average amongst peers. Net Margin: Kymera Rehabs’s net margin falls listed below market averages, showing obstacles in accomplishing strong success. With a net margin of
-667.6%, the business might deal with difficulties in efficient expense management. Return on Equity (ROE): Kymera Rehabs’s ROE is listed below market requirements, pointing towards problems in effectively using equity capital. With an ROE of
-8.72%, the business might experience obstacles in providing acceptable returns for investors. Return on Properties (ROA): The business’s ROA is listed below market standards, signifying prospective problems in effectively using possessions. With an ROA of
-7.48%, the business might require to deal with obstacles in producing acceptable returns from its possessions. Financial Obligation Management: With a below-average debt-to-equity ratio of
0.09, Kymera Rehabs embraces a sensible monetary method, showing a well balanced method to financial obligation management. Expert Rankings: What Are They? Specialists in banking and monetary systems, experts focus on reporting for particular stocks or specified sectors. Their extensive research study includes participating in business teleconference and conferences, examining monetary declarations, and engaging with experts to produce what are called expert rankings for stocks. Generally, experts evaluate and rank each stock when per quarter.
Beyond their basic examinations, some experts contribute forecasts for metrics like development quotes, incomes, and earnings, providing financiers with extra assistance. Users of expert rankings ought to be conscious that this specialized recommendations is formed by human viewpoints and might go through irregularity.
Which Stocks Are Experts Advising Now?
Benzinga Edge provides you instantaneous access to all significant expert upgrades, downgrades, and cost targets. Sort by precision, upside prospective, and more.
Click on this link to remain ahead of the marketplace
This short article was produced by Benzinga’s automatic material engine and evaluated by an editor.